Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

  1. Llovera, M.
  2. Pichard, C.
  3. Bernichtein, S.
  4. Jeay, S.
  5. Touraine, P.
  6. Kelly, P.A.
  7. Goffin, V.
Journal:
Oncogene

ISSN: 0950-9232

Year of publication: 2000

Volume: 19

Issue: 41

Pages: 4695-4705

Type: Article

DOI: 10.1038/SJ.ONC.1203846 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus